Recent changes
Track the most recent changes to the wiki on this page.
17 June 2021
| 09:37 | B-cell acute lymphoblastic leukemia, pediatric (26 changes | history) . . (+14,700) . . [Cafitts (26×)] | ||
| 09:37 (cur | prev) . . (+92) . . Cafitts (talk | contribs) | |||
| 09:34 (cur | prev) . . (+3,265) . . Cafitts (talk | contribs) | |||
| 09:33 (cur | prev) . . (+191) . . Cafitts (talk | contribs) (→CNS prophylaxis) | |||
| 09:32 (cur | prev) . . (+13) . . Cafitts (talk | contribs) (→Chemotherapy) | |||
| 09:30 (cur | prev) . . (+26) . . Cafitts (talk | contribs) (→Chemotherapy) | |||
| 09:29 (cur | prev) . . (+1) . . Cafitts (talk | contribs) (→Chemotherapy) | |||
| 09:29 (cur | prev) . . (+12) . . Cafitts (talk | contribs) (→Chemotherapy) | |||
| 09:27 (cur | prev) . . (+2,172) . . Cafitts (talk | contribs) | |||
| 09:25 (cur | prev) . . (0) . . Cafitts (talk | contribs) (→CNS prophylaxis) | |||
| 09:25 (cur | prev) . . (0) . . Cafitts (talk | contribs) (→CNS prophylaxis) | |||
| 09:24 (cur | prev) . . (+191) . . Cafitts (talk | contribs) (→CNS prophylaxis) | |||
| 09:23 (cur | prev) . . (+1,106) . . Cafitts (talk | contribs) (→Mercaptopurine, Methotrexate, Vincristine {{#subobject:72025a|Regimen=1}}) | |||
| 09:22 (cur | prev) . . (+1,939) . . Cafitts (talk | contribs) (→Interim Maintenance I) | |||
| 09:20 (cur | prev) . . (+28) . . Cafitts (talk | contribs) | |||
| 09:17 (cur | prev) . . (+192) . . Cafitts (talk | contribs) (→CNS prophylaxis) | |||
| 09:15 (cur | prev) . . (+1,757) . . Cafitts (talk | contribs) (→Consolidation) | |||
| 08:44 (cur | prev) . . (+19) . . Cafitts (talk | contribs) | |||
| 08:41 (cur | prev) . . (+190) . . Cafitts (talk | contribs) | |||
| 08:39 (cur | prev) . . (+21) . . Cafitts (talk | contribs) (→CNS prophylaxis) | |||
| 08:38 (cur | prev) . . (+429) . . Cafitts (talk | contribs) | |||
| 08:33 (cur | prev) . . (-15) . . Cafitts (talk | contribs) | |||
| 08:32 (cur | prev) . . (+15) . . Cafitts (talk | contribs) | |||
| 08:30 (cur | prev) . . (+1) . . Cafitts (talk | contribs) | |||
| 08:29 (cur | prev) . . (+57) . . Cafitts (talk | contribs) | |||
| 08:25 (cur | prev) . . (-9) . . Cafitts (talk | contribs) | |||
| 08:24 (cur | prev) . . (+3,007) . . Cafitts (talk | contribs) |
16 June 2021
| m 07:44 | Venous thromboembolism (diff | hist) . . (+235) . . Jwarner (talk | contribs) (→VTE treatment, all lines of therapy) |
| m 07:33 | Multiple myeloma, relapsed-refractory (diff | hist) . . (+671) . . Jwarner (talk | contribs) |
15 June 2021
| m 21:34 | Multiple myeloma, relapsed-refractory (2 changes | history) . . (-237) . . [Jwarner (2×)] | ||
| m | 21:34 (cur | prev) . . (-229) . . Jwarner (talk | contribs) | ||
| m | 20:54 (cur | prev) . . (-8) . . Jwarner (talk | contribs) (→References) |
| m 21:00 | Endometrial cancer - null regimens (diff | hist) . . (-17) . . Jwarner (talk | contribs) (→Placebo) |
| m 20:58 | Multiple myeloma - historical (diff | hist) . . (+51) . . Jwarner (talk | contribs) (→Urethane monotherapy {{#subobject:9ihjbsb|Regimen=1}}) |
| m 20:47 | Hodgkin lymphoma (diff | hist) . . (+61) . . Jwarner (talk | contribs) |
| m 20:44 | Follicular lymphoma - historical (diff | hist) . . (+89) . . Jwarner (talk | contribs) (→FMP {{#subobject:f1669a|Regimen=1}}) |
| m 20:42 | Diffuse large B-cell lymphoma - historical (2 changes | history) . . (+414) . . [Jwarner (2×)] | ||
| m | 20:42 (cur | prev) . . (+345) . . Jwarner (talk | contribs) | ||
| m | 20:39 (cur | prev) . . (+69) . . Jwarner (talk | contribs) (→References) |
| m 20:40 | Breast cancer (2 changes | history) . . (+138) . . [Jwarner (2×)] | ||
| m | 20:40 (cur | prev) . . (+62) . . Jwarner (talk | contribs) (→References) | ||
| m | 20:23 (cur | prev) . . (+76) . . Jwarner (talk | contribs) (→References) |
| m 20:28 | Glioblastoma (2 changes | history) . . (+287) . . [Jwarner (2×)] | ||
| m | 20:28 (cur | prev) . . (+77) . . Jwarner (talk | contribs) (→CART-EGFRvIII cells {{#subobject:ed311c|Regimen=1}}) | ||
| m | 20:22 (cur | prev) . . (+210) . . Jwarner (talk | contribs) |
| m 20:26 | Leiomyosarcoma (diff | hist) . . (+142) . . Jwarner (talk | contribs) |
| m 20:25 | Liposarcoma (diff | hist) . . (+142) . . Jwarner (talk | contribs) |
| m 20:24 | Small cell lung cancer - historical (diff | hist) . . (+77) . . Jwarner (talk | contribs) (→CDE {{#subobject:fd0ec6|Regimen=1}}) |
| m 20:20 | Hodgkin lymphoma - historical (2 changes | history) . . (+129) . . [Jwarner (2×)] | ||
| m | 20:20 (cur | prev) . . (+67) . . Jwarner (talk | contribs) (→SCAB {{#subobject:04355f|Regimen=1}}) | ||
| m | 20:20 (cur | prev) . . (+62) . . Jwarner (talk | contribs) (→References) |
| m 16:48 | Ivosidenib (Tibsovo) (diff | hist) . . (+68) . . Jwarner (talk | contribs) |
14 June 2021
| m 21:57 | Cervical cancer (diff | hist) . . (+85) . . Jwarner (talk | contribs) (→FULV {{#subobject:e38061|Regimen=1}}) |
| m 21:55 | Extranodal NK- and T-cell lymphoma, nasal type (diff | hist) . . (+56) . . Jwarner (talk | contribs) (→L-Asparaginase, Vincristine, Prednisolone {{#subobject:1ba9b6|Regimen=1}}) |
| m 21:54 | Waldenström macroglobulinemia (diff | hist) . . (+67) . . Jwarner (talk | contribs) (→Fludarabine monotherapy {{#subobject:8df670|Regimen=1}}) |
| m 21:52 | Multiple myeloma, consolidation and maintenance (diff | hist) . . (+1,082) . . Jwarner (talk | contribs) (→Lenalidomide monotherapy {{#subobject:1bb17c|Regimen=1}}) |
